Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
podcast
Podcast
Novo Nordisk’s CFO on the oral Wegovy rollout and beyond
Novo Nordisk's CFO joins “The Top Line” to discuss oral Wegovy’s rollout, the company’s raised outlook and why he’s still optimistic about CagriSema.
Ayla Ellison
,
James Waldron
Aug 7, 2026 8:42am
5 emerging biotech hubs
Jul 17, 2026 9:18am
The deal before the deal
Jun 26, 2026 9:20am
Ipsen R&D chief on pipeline discipline and 2026 milestones
Jun 12, 2026 9:57am
Boston, China and the future of biotech
May 29, 2026 9:09am
BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions
May 22, 2026 10:00am
